The real world data of patient outcomes associated with different sequencing approaches in patients with Newly Diagnosed Multiple Myeloma (NDMM) followed By Autologous Stem Cell Transplant (ASCT).
Phase of Trial: Phase IV
Latest Information Update: 29 Dec 2017
Price : $35 *
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone (Primary) ; Lenalidomide (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 29 Dec 2017 New trial record
- 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology.